Biopesticides products maker Eden Research said it had received authorisation for the sale of its bio-fungicide in Australia, for use on wine and table grapes. The product, authorised and marketed under the trade name 'Novellus,' was used as a 'sustainable and residue-free solution for the common disease Botrytis cinerea, a fungal pathogen affecting many plant species, which causes an annual economic loss of more than $10bn worldwide,' the company said. Australia, a key market for Eden and its commercial partner Sipcam, who would distribute the product. Wine grapes made up an estimated 60.3% of Australian grape crop revenue, and in 2019, the country produced circa 12m hectolitres of wine. At 10:03am: (LON:EDEN) Eden Research plc share price was +0.18p at 7.25p
Sign up to our
Subscribe to the latest investing news by entering your email address below
You can opt out at any time.
For five days a week you will get
- The latest company news
- Insight into investment trends
- Round-up of director's buys and sells
- Articles from Shares magazine
Plus more useful investment content and occasional promotional offers.
UK 350 Risers and Fallers
Tweets not available.